Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax RateTax Rate
Others
Ratios

Forte Biosciences (FBRX) Interest Expenses (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Interest Expenses for 5 consecutive years, with $756000.0 as the latest value for Q1 2020.

  • Quarterly Interest Expenses changed 0.27% to $756000.0 in Q1 2020 from the year-ago period, while the trailing twelve-month figure was $756000.0 through Dec 2020, down 80.21% year-over-year, with the annual reading at $3.8 million for FY2019, 30.38% up from the prior year.
  • Interest Expenses for Q1 2020 was $756000.0 at Forte Biosciences, up from $330000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $2.0 million in Q3 2019, with the low at $330000.0 in Q4 2019.
  • Average Interest Expenses over 5 years is $675941.2, with a median of $533000.0 recorded in 2016.
  • Peak annual rise in Interest Expenses hit 165.9% in 2019, while the deepest fall reached 55.76% in 2019.
  • Over 5 years, Interest Expenses stood at $533000.0 in 2016, then decreased by 26.64% to $391000.0 in 2017, then skyrocketed by 90.79% to $746000.0 in 2018, then plummeted by 55.76% to $330000.0 in 2019, then skyrocketed by 129.09% to $756000.0 in 2020.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $756000.0, $330000.0, and $2.0 million for Q1 2020, Q4 2019, and Q3 2019 respectively.